Rickard Ljung
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 176 publications
Adapted XBB.1.5 vaccine effectiveness against severe COVID-19 outcomes among immunocompromised persons in 2023-24 in six European countries: a VEBIS-EHR network study.
Journal: Expert review of vaccines
Published: July 27, 2026
Cholecystectomy vs Endoscopic Retrograde Cholangiopancreatography or No Intervention After Gallstone-Related Acute Pancreatitis.
Journal: JAMA surgery
Published: June 24, 2026
Feasibility of conducting brand-specific influenza vaccine effectiveness studies in three Nordic countries, Denmark, Finland, Sweden.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: February 27, 2026
Comorbidity indices in observational studies on cardiovascular risk.
Journal: Open heart
Published: January 23, 2026
Trends in age-sex-specific prevalence and incidence of antidepressant dispensation in the Nordic countries: a systematic review.
Journal: British journal of clinical pharmacology
Published: November 25, 2025
Comorbidity indices in observational studies on cancer risk.
Journal: Acta oncologica (Stockholm, Sweden)
Published: November 18, 2025
Acute pancreatitis in relation to SARS-CoV-2 vaccination and infection: A nationwide cohort study in Sweden.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: September 17, 2025
Spontaneous Reports of Adverse Reactions with Fatal Outcomes After COVID-19 Vaccination During the National Vaccination Campaign in Sweden.
Journal: Clinical drug investigation
Published: July 22, 2025
Brand-specific influenza vaccine effectiveness in three Nordic countries during the 2024-2025 season: a target trial emulation study based on registry data.
Journal: The Lancet regional health. Europe
Published: July 18, 2025
Effectiveness of JN.1 monovalent COVID-19 vaccination in EU/EEA countries between October 2024 and January 2025: a VEBIS electronic health record network study.
Journal: Vaccine
Published: July 16, 2025
Last Updated: 09/26/2026